International network of cancer genome projects
Thomas J Hudson(Ontario Institute for Cancer Research), Warwick Anderson, Axel Artez, Anna D Barker(National Institutes of Health), Cindy Bell, Rosa R Bernabé, M K Bhan, Fabien Calvo, Fabien Calvo, Iiro Eerola(National Institutes of Health), Daniela S. Gerhard(National Institutes of Health), Alan F. Guttmacher(National Institutes of Health), Mark S. Guyer, Jennifer L Jennings(Ontario Institute for Cancer Research), Jennifer L. Jennings(University of Oxford), David Kerr, Peter Klatt, Patrik Kolar(The University of Osaka), David P Lane, David P. Lane, Frank Laplace(Chinese Academy of Medical Sciences & Peking Union Medical College), Gerd Nettekoven, Gerd Nettekoven(National Institutes of Health), Brad Ozenberger(National Institutes of Health), T S Rao, T. S. Rao, Jacques Remacle(Wellcome Trust), Tatsuhiro Shibata(National Cancer Research Institute), Tatsuhiro Shibata, Joseph G Vockley(National Institutes of Health), Joseph G. Vockley, Koichi Watanabe, Huanming Yang(Hong Kong University of Science and Technology), M.M.F. Yuen(McGill University), Martin Bobrow(University of Cambridge), Martin Bobrow(Inserm), Anne Cambon‐Thomsen(University of North Carolina at Chapel Hill), Lynn G. Dressler, Yann Joly(McGill University), Yann Joly(Kyoto University), Karen L Kennedy, Pilar Nicolás(Universidad de Deusto), Pilar Nicolás(University of Oxford), Michael Parker(Inserm), Emmanuelle Rial‐Sebbag(Universidad de Deusto), Carlos M. Romeo-Casabona(National Institutes of Health), Susan Wallace(McGill University), Susan Wallace(Case Western Reserve University), Georgia L. Wiesner(The University of Western Australia), Nikolajs Zeps(German Cancer Research Center), Andrew V Biankin(UNSW Sydney), Christian Chabannon, Christian Chabannon(Harvard University Press), Bruno Clément(Inserm), Bruno Clément, Françoise Degos, Françoise Degos, Peter Geary, Peter Geary(University of North Carolina at Chapel Hill), D. Neil Hayes(UNSW Sydney), Thomas J. Hudson(Ontario Institute for Cancer Research), Amber L. Johns, Hidewaki Nakagawa, Hidewaki Nakagawa, Miguel A Piris, Miguel Á. Piris(University of Verona), Rajiv Sarin(Amsterdam University of the Arts), Aldo Scarpa, Marc van de Vijver(The University of Tokyo), Marc J. van de Vijver, P. Andrew Futreal(The University of Melbourne), Hiroyuki Aburatani(University of Cambridge), Mónica Bayés, Peter J Campbell(The University of Queensland), Xavier Estivill, Xavier Estivill(University of British Columbia), Sean M Grimmond(Universidad de Oviedo), Sean M. Grimmond, Martin Hirst(University of British Columbia), Martin Hirst(Ontario Institute for Cancer Research), Partha Majumder, Marco Marra(Universidad de Oviedo), Marco A. Marra(Agency for Science, Technology and Research), John D. McPherson(Radboud University Nijmegen), Hidewaki Nakagawa, Zemin Ning(Johns Hopkins University), Yijun Ruan(Washington University in St. Louis), Yijun Ruan(Hong Kong University of Science and Technology), Michael R Stratton(Zhejiang University), Hendrik G Stunnenberg(Lawrence Berkeley National Laboratory), Harold Swerdlow(University of Toronto), Harold Swerdlow(Ontario Institute for Cancer Research), Victor E. Velculescu, Hong H Xue(Massachusetts Institute of Technology), Liu Yang, Liu Yang, Gary D Bader(University of California, Santa Cruz), Gary D. Bader, Paul C. Boutros, Paul Flicek, Paul Flicek(University of British Columbia), Gad Getz, Roderic Guigó(Universitat Pompeu Fabra), Guangwu Guo, David Haussler(Ontario Institute for Cancer Research), Tim J Hubbard(Ontario Institute for Cancer Research), Tao Jiang(The University of Queensland), Tao Jiang(Universidad de Oviedo), Qibin Li(Brown University), Qibin Li(Memorial Sloan Kettering Cancer Center), Ruibang Luo(Walter and Eliza Hall Institute of Medical Research), Ruibang Luo(Ontario Institute for Cancer Research), B F Francis Ouellette(University of California, Santa Cruz), B. F. Francis Ouellette, John V. Pearson(National Cancer Research Institute), Xosé S. Puente, Vı́ctor Quesada, Benjamin J. Raphael(Baylor College of Medicine), Chris Sander, Terence P Speed, Terence P. Speed, Joshua M Stuart, Joshua M. Stuart(Université Claude Bernard Lyon 1), Yasushi Totoki(National Cancer Research Institute), Yasushi Totoki, Alfonso Valencia, David A Wheeler, Honglong Wu(Ontario Institute for Cancer Research), Honglong Wu(University of Cambridge), Shancen Zhao(Ontario Institute for Cancer Research), Guangyu Zhou(Ontario Institute for Cancer Research), Roderic Guigó(Ontario Institute for Cancer Research), Roderic Guigó(Ontario Institute for Cancer Research), Yann Joly(Ontario Institute for Cancer Research), Steven M Jones(Ontario Institute for Cancer Research), Arek Kasprzyk(Ontario Institute for Cancer Research), Mark Lathrop(University of Tasmania), Nuria López-Bigas, B F Francis Ouellette(National University of Singapore), B. F. Francis Ouellette, Paul T. Spellman(The University of Osaka), Gilles Thomas(National Institutes of Health), Alfonso Valencia, Teruhiko Yoshida(The University of Melbourne), Teruhiko Yoshida(The University of Queensland), Myles Axton(The University of Sydney), Myles Axton(Johns Hopkins University), P Andrew Futreal(The University of Melbourne), Daniela S Gerhard(The University of Queensland), Chris Gunter(UNSW Sydney), Mark Guyer(UNSW Sydney), Mark S. Guyer(University of California, San Francisco), John D McPherson(The University of Queensland), Linda J Miller(The University of Queensland), Linda J. Miller(University Health Network), Brad Ozenberger(National Institutes of Health), Arek Kasprzyk(University Health Network), Lincoln D Stein(Mayo Clinic), Junjun Zhang(Mayo Clinic), Junjun Zhang(Harvard University Press), Syed Haider(Harvard University Press), Jianxin Wang(Ontario Institute for Cancer Research), Christina K. Yung(Ontario Institute for Cancer Research), Anthony Cross(Ontario Institute for Cancer Research), Anthony Cross(Ontario Institute for Cancer Research), Yong Liang(Ontario Institute for Cancer Research), Saravanamuttu Gnaneshan(Chinese Academy of Medical Sciences & Peking Union Medical College), Jonathan M. Guberman, Jack Shih‐Chieh Hsu(Chinese Academy of Medical Sciences & Peking Union Medical College), Martin Bobrow, Drc Chalmers, Karl W. Hasel, Terry S H Kaan(Chinese Academy of Medical Sciences & Peking Union Medical College), Terry Sheung-Hung Kaan(Chinese Academy of Medical Sciences & Peking Union Medical College), Bartha M Knoppers(Chinese Academy of Medical Sciences & Peking Union Medical College), William W Lowrance(Shanghai Jiao Tong University), William W. Lowrance(Shanghai Jiao Tong University), Tohru Masui(Chinese University of Hong Kong), Pilar Nicolás, Emmanuelle Rial‐Sebbag(Centre international de recherche sur le cancer), Laura Lyman Rodriguez(Charles University), Catherine Vergely(Russian Academy of Sciences), Teruhiko Yoshida, Andrew V Biankin(Karolinska Institutet), David D L Bowtell(Russian Academy of Sciences), David D.L. Bowtell, Nicole Cloonan(KTH Royal Institute of Technology), Anna DeFazio(University of Latvia), James R. Eshleman(Uppsala University), Dariush Etemadmoghadam, Brooke A. Gardiner(Karolinska Institutet), Brooke A. Gardiner, James G. Kench(Lund University), Aldo Scarpa(University of Oslo), Robert L. Sutherland(University of Cambridge), Margaret A. Tempero(Erasmus University Rotterdam), Peter J Wilson, Peter J. Wilson, Steve Gallinger(Harvard University Press), Steve Gallinger(Université Libre de Bruxelles), Patricia A Shaw, Patricia Shaw, Gloria M. Petersen, Debabrata Mukhopadhyay, Ronald A DePinho, Sarah Thayer, Sarah P. Thayer, Kamran Shazand, Kamran Shazand(Institut Curie), Timothy Beck, Michelle Sam, Lee E. Timms, Vanessa Ballin, Youyong Lu, Jiafu Ji, Xiuqing Zhang, Feng Chen, Xueda Hu(Inserm), Guangyu Zhou(Inserm), Qi Yang(German Cancer Research Center), Geng Tian(German Cancer Research Center), Lianhai Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaofang Xing(Heidelberg University), Xianghong Li(Heinrich Heine University Düsseldorf), Zhenggang Zhu(Max Planck Society), Yingyan Yu(German Cancer Research Center), Jun Yu(German Cancer Research Center), Huanming Yang(Heinrich Heine University Düsseldorf), Mark Lathrop(University of Toronto), Jörg Tost(German Cancer Research Center), Paul Brennan(University Health Network), Ivana Holcátová, Давид Заридзе, Alvis Brāzma(University of Verona), Egor Prokhortchouk(University of Turin), Egor Prokhortchouk(Philipps University of Marburg), Rosamonde E. Banks(Memorial Sloan Kettering Cancer Center), Mathias Uhlén(University of Verona), Anne Cambon‐Thomsen(The University of Tokyo), Juris Vīksna(The University of Tokyo), Fredrik Pontén, Konstantin Skryabin(Universitat de Barcelona), P Andrew Futreal, Ewan Birney(Universitat de Barcelona), Ewan Birney, Ake Borg(Universitat de Barcelona), Carlos Caldas, Carlos Caldas(Universitat de Barcelona), Sancha Martin(University of British Columbia), Sancha Martin(University of Cambridge), Jorge S. Reis-Filho(National Institutes of Health), Andrea L. Richardson(National Institutes of Health), Christos Sotiriou(Massachusetts Institute of Technology), Giles Thoms(University of Washington), Marc van de Vijver(University of Cambridge), Marc J. van de Vijver(The University of Texas MD Anderson Cancer Center), Fabien Calvo(University of Helsinki), Fabien Calvo(Washington University in St. Louis), Daniel Birnbaum(Agency for Science, Technology and Research), Hélène Blanché(The University of Queensland), Pascal Boucher, Sandrine Boyault, Christian Chabannon, Jocelyne D Masson-Jacquemier, Mark Lathrop, Mark Lathrop, Iris Pauporté, Xavier Pivot, Anne Vincent‐Salomon, Éric Tabone, Charles Theillet, Jörg Tost, Jörg Tost, Isabelle Treilleux, Fabien Calvo, Paulette Bioulac‐Sage, Bruno Clément, Thomas Decaens, Françoise Degos, Dominique Franco, Marta Gut, Marta Gut, Mark Lathrop, Didier Samuel, Didier Samuel, Jessica Zucman-Rossi, Jessica Zucman‐Rossi, Roland Eils, Roland Eils, Benedikt Brors, Andrey Korshunov, Andrey Korshunov, Pablo Landgraf, Hans Lehrach, Stefan M. Pfister, Bernhard Radlwimmer, Guido Reifenberger, Michael D. Taylor, Christof von Kalle, Partha Majumder, Rajiv Sarin, T. S. Rao, Aldo Scarpa, Aldo Scarpa, Paolo Pederzoli, Massimo Delledonne, Massimo Delledonne, Alberto Bardelli, Sean M Grimmond, Thomas Gress, Thomas M. Gress, David S. Klimstra, Giuseppe Zamboni, Tatsuhiro Shibata, Yusuke Nakamura, Hidewaki Nakagawa, Tatsuhiko Tsunoda, Satoru Miyano, Satoru Miyano, Hiroyuki Aburatani, Akihiro Fujimoto, Akihiro Fujimoto, Teruhiko Yoshida, Elı́as Campo, Xavier Estivill, Xavier Estivill, Roderic Guigó, Silvia de Sanjosé, Miguel Á. Piris, Emili Montserrat, Xose S Puente, Pedro Jares, Pedro Jares, Alfonso Valencia, Heinz Himmelbaue, Heinz Himmelbaue, Vı́ctor Quesada, Sı́lvia Beà, P Andrew Futreal, Peter J Campbell, Anne Vincent-Salomon, Anne Vincent‐Salomon, Andrea L. Richardson, Jorge S. Reis-Filho, Marc J. van de Vijver, Jocelyne D Masson-Jacquemier, Samuel Aparicio, Samuel Aparício, Ake Borg, Carlos Caldas, Carlos Caldas, Hendrik G Stunnenberg, Laura van't Veer, Douglas F Easton, Douglas F. Easton, Sancha Martin, Sancha Martin, Lynda Chin, Francis S Collins, Carolyn C Compton, Martin L Ferguson, Daniela S Gerhard, Gad Getz, Gad Getz, Alan Guttmacher, Alan F. Guttmacher, Mark S. Guyer, D. Neil Hayes, Eric S. Lander, Robert Penny, Jane Peterson, Jane L. Peterson, Chris Sander, Terence P Speed, Terence P. Speed, Paul T. Spellman, Joseph G. Vockley, Richard K Wilson, Thomas J Hudson, Thomas J. Hudson, Bartha M Knoppers, Eric S Lander, Eric S. Lander, Peter Lichter, Michael R Stratton, Warwick Anderson, Anna D Barker, Anna D. Barker, Martin Bobrow, Martin Bobrow, Wylie Burke, Carolyn C Compton, Ronald A DePinho, Douglas F Easton, Douglas F. Easton, Daniela S Gerhard, Daniela S. Gerhard, Anthony R. Green, Mark S. Guyer, Stanley R. Hamilton, Olli P Kallioniemi, Olli Kallioniemi, Timothy J Ley, Timothy J. Ley, Edison T. Liu, Youyong Lu, Marco Marra, Marco A. Marra, Jane Peterson, Alan J Schafer, Paul T Spellman, Hendrik G Stunnenberg, Brandon J Wainwright, Brandon J. Wainwright, Huanming Yang
Cited by 2,409Open Access
Abstract
The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.
Related Papers
No related papers found
Powered by citation graph analysis